SANDS ARTHUR T 4
4 · Nurix Therapeutics, Inc. · Filed Oct 23, 2020
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPresident, CEO
Transactions
- Award
Stock Option (right to buy)
2020-10-21+804,170→ 804,170 totalExercise: $26.91Exp: 2030-10-20→ Common Stock (804,170 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/48 of the total shares monthly beginning August 23, 2020 until the option is fully vested on July 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.